Aclaris Therapeutics Vs. ResMed Industry Stock Comparison

Sell

20

ACRS
Aclaris Therapeutics

Last Price:

1.11

Seasonality Move:

-6.56%

Sell

30

RMD
ResMed

Last Price:

191.79

Seasonality Move:

6.67%

Sell

20

Aclaris Therapeutics (ACRS) is a Sell

Is Aclaris Therapeutics a Buy, Sell or Hold?

The current Aclaris Therapeutics [ACRS] share price is $1.12. The Score for ACRS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

30

ResMed (RMD) is a Sell

Is ResMed a Buy, Sell or Hold?

The current ResMed [RMD] share price is $191.42. The Score for RMD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
RMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACRS Stock Price Chart

What is Aclaris Therapeutics's stock price today?

The Aclaris Therapeutics share price today is $1.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight selling pressure.

RMD Stock Price Chart

What is ResMed's stock price today?

The ResMed share price today is $191.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RMD is experiencing slight selling pressure.

ACRS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0	Buy
Relative Strength Index (14 RSI):	47.6	Sell
Chaikin Money Flow:	-1016243	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.04 - 1.18)	Buy
Bollinger Bands (100):	(1.11 - 1.27)	Sell

RMD Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-5.24	Sell
Relative Strength Index (14 RSI):	36.96	Sell
Chaikin Money Flow:	-790759	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(195.99 - 215.37)	Sell
Bollinger Bands (100):	(182.26 - 211.22)	Sell

ACRS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.17	Sell
20-day SMA:	1.12	Buy
50-day SMA:	1.17	Sell
200-day SMA:	2.15	Sell
8-day EMA:	1.15	Sell
20-day EMA:	1.14	Sell
50-day EMA:	1.16	Sell
200-day EMA:	2.76	Sell

RMD Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	195.87	Sell
20-day SMA:	204.74	Sell
50-day SMA:	207.09	Sell
200-day SMA:	177.56	Buy
8-day EMA:	194.67	Sell
20-day EMA:	201.7	Sell
50-day EMA:	203.15	Sell
200-day EMA:	191.93	Sell

Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.

ResMed Earnings Growth & RMD Earnings Dates

Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.

Aclaris Therapeutics Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ResMed Technical Analysis

	Jun 14	Jun 17	Jun 18	Jun 20	Jun 21	Jun 24	Jun 25	Jun 26	Jun 27	Jun 28
	Jun
	14	17	18	20	21	24	25	26	27	28
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):